Literature DB >> 10837637

Receptor versus non-receptor mediated clearance of liposomes.

.   

Abstract

Numerous studies have appeared over the years dealing with liposome-cell interaction mechanisms, most of them performed under in vitro conditions with isolated cell populations or cell lines. It is remarkable that, nonetheless, there hardly seem to exist established and generally accepted views on how precisely liposomes interact with cells and by what parameters this is influenced. In this article we will summarize and discuss the most relevant studies (in our opinion) on this matter in relation to in vivo conditions and with special attention to the relation between scavenger, complement and PS receptors.Researchers in the field have long been aware of the interaction of liposomes with blood proteins and their potential involvement in the process of liposome elimination from the blood circulation. A few of these 'opsonizing' proteins have been identified, but it is not clear to what extent each of them determines the fate of the liposome in the blood stream and how liposomal parameters such as size, charge and rigidity play a role in this process. We will include in this article our own recent observations on a thus far largely ignored class of such liposomal 'opsonins', the apolipoproteins. This class of plasma proteins, which physiologically are instrumental in hepatic lipoprotein clearance and processing, has been shown to contribute specifically to hepatocyte-mediated uptake of liposomes.Separately, as opposed to the fate of plain liposomes, we briefly touch on the clearance of surface-modified liposomes, which are designed to actively target specific cells or tissues. Plasma proteins are not usually supposed to play a significant role in the clearance of such liposomes. We will summarize these studies and address in this connection the question of how plasma proteins may interfere with such active targeting attempts.

Entities:  

Year:  1998        PMID: 10837637     DOI: 10.1016/s0169-409x(97)00133-6

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  23 in total

Review 1.  Recognition by macrophages and liver cells of opsonized phospholipid vesicles and phospholipid headgroups.

Authors:  S M Moghimi; A C Hunter
Journal:  Pharm Res       Date:  2001-01       Impact factor: 4.200

Review 2.  Design considerations for liposomal vaccines: influence of formulation parameters on antibody and cell-mediated immune responses to liposome associated antigens.

Authors:  Douglas S Watson; Aaron N Endsley; Leaf Huang
Journal:  Vaccine       Date:  2012-02-02       Impact factor: 3.641

Review 3.  Nanocarriers' entry into the cell: relevance to drug delivery.

Authors:  Hervé Hillaireau; Patrick Couvreur
Journal:  Cell Mol Life Sci       Date:  2009-06-05       Impact factor: 9.261

4.  Microfluidic preparation of liposomes to determine particle size influence on cellular uptake mechanisms.

Authors:  Abhay U Andar; Renee R Hood; Wyatt N Vreeland; Don L Devoe; Peter W Swaan
Journal:  Pharm Res       Date:  2013-10-03       Impact factor: 4.200

5.  Ligands located within a cholesterol domain enhance gene delivery to the target tissue.

Authors:  Long Xu; Jamie Betker; Hao Yin; Thomas J Anchordoquy
Journal:  J Control Release       Date:  2012-03-09       Impact factor: 9.776

6.  MARCO regulates early inflammatory responses against influenza: a useful macrophage function with adverse outcome.

Authors:  Sanjukta Ghosh; David Gregory; Alexia Smith; Lester Kobzik
Journal:  Am J Respir Cell Mol Biol       Date:  2011-05-11       Impact factor: 6.914

7.  Different effect of hydrogelation on antifouling and circulation properties of dextran-iron oxide nanoparticles.

Authors:  Priya Prakash Karmali; Ying Chao; Ji-Ho Park; Michael J Sailor; Erkki Ruoslahti; Sadik C Esener; Dmitri Simberg
Journal:  Mol Pharm       Date:  2012-02-02       Impact factor: 4.939

Review 8.  Drug delivery trends in clinical trials and translational medicine: challenges and opportunities in the delivery of nucleic acid-based therapeutics.

Authors:  Long Xu; Thomas Anchordoquy
Journal:  J Pharm Sci       Date:  2011-01       Impact factor: 3.534

9.  Therapeutic inflammatory monocyte modulation using immune-modifying microparticles.

Authors:  Daniel R Getts; Rachael L Terry; Meghann Teague Getts; Celine Deffrasnes; Marcus Müller; Caryn van Vreden; Thomas M Ashhurst; Belal Chami; Derrick McCarthy; Huiling Wu; Jin Ma; Aaron Martin; Lonnie D Shae; Paul Witting; Geoffrey S Kansas; Joachim Kühn; Wali Hafezi; Iain L Campbell; David Reilly; Jana Say; Louise Brown; Melanie Y White; Stuart J Cordwell; Steven J Chadban; Edward B Thorp; Shisan Bao; Stephen D Miller; Nicholas J C King
Journal:  Sci Transl Med       Date:  2014-01-15       Impact factor: 17.956

10.  Differential proteomics analysis of the surface heterogeneity of dextran iron oxide nanoparticles and the implications for their in vivo clearance.

Authors:  Dmitri Simberg; Ji-Ho Park; Priya P Karmali; Wan-Ming Zhang; Sergei Merkulov; Keith McCrae; Sangeeta N Bhatia; Michael Sailor; Erkki Ruoslahti
Journal:  Biomaterials       Date:  2009-04-26       Impact factor: 12.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.